title: Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor.
abstract: The switch between the latency and lytic cycles of Kaposi's sarcoma-associated herpesvirus (KSHV) is accompanied by specific alterations of histone codes. Recently, comprehensive analysis of histone modifications of KSHV showed the deposition of H3K27me3 across the KSHV genome with two specific regions occupied by the heterochromatin marker H3K9me3. Here, we show that knockdown of JMJD2A, an H3K9me3 demethylase, attenuates viral titers, whereas its overexpression increases KSHV reactivation. JMJD2A is localized in regions of latent viral chromosomes that are deficient in the H3K9me3 mark, indicating that JMJD2A may be responsible for the low level of this mark on viral chromatin. The presence of JMJD2A on the latent genome maintains H3K9 in unmethylated form and signals the readiness of specific sets of viral genes to be reactivated. The demethylase activity of JMJD2A is important for KSHV reactivation, because a demethylase-deficient mutant cannot restore the JMJD2A knockdown phenotype. Interestingly, we found that the KSHV encoded K-bZIP associated with JMJD2A, resulting in the inhibition of demethylase activity of JMJD2A both in vivo and in vitro. Inhibition of JMJD2A by K-bZIP is likely due to a physical interaction which blocks substrate accessibility. A consequence of such an inhibition is increasing global levels of H3K9me3 and gene silencing. Consistently, K-bZIP overexpression resulted in a repression of ∼80% of the ≥2-fold differentially regulated genes compared to results for the uninduced control cells. The consequences of K-bZIP targeting JMJD2A during viral replication will be discussed. To our knowledge, this is the first description of a viral product shown to be a potent inhibitor of a host cellular histone demethylase.
authors.affiliation: Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
authors.forename: Pei-Ching
authors.initials: PC
authors.lastname: Chang
authors.forename: Latricia D
authors.initials: LD
authors.lastname: Fitzgerald
authors.forename: Datsun A
authors.initials: DA
authors.lastname: Hsia
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Izumiya
authors.forename: Chun-Yi
authors.initials: CY
authors.lastname: Wu
authors.forename: Wen-Ping
authors.initials: WP
authors.lastname: Hsieh
authors.forename: Su-Fang
authors.initials: SF
authors.lastname: Lin
authors.forename: Mel
authors.initials: M
authors.lastname: Campbell
authors.forename: Kit S
authors.initials: KS
authors.lastname: Lam
authors.forename: Paul A
authors.initials: PA
authors.lastname: Luciw
authors.forename: Clifford G
authors.initials: CG
authors.lastname: Tepper
authors.forename: Hsing-Jien
authors.initials: HJ
authors.lastname: Kung
mesh_terms: D050976:Basic-Leucine Zipper Transcription Factors / Q000378:metabolism*; D055785:Gene Knockdown Techniques; D005816:Genetic Complementation Test; D019288:Herpesvirus 8, Human / Q000472:pathogenicity*; D054884:Host-Pathogen Interactions; D006801:Humans; D056484:Jumonji Domain-Containing Histone Demethylases / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D025941:Protein Interaction Mapping; D012097:Repressor Proteins / Q000378:metabolism*; D019562:Viral Load; D014764:Viral Proteins / Q000378:metabolism*; D017735:Virus Latency; D014779:Virus Replication
chemical_list: D050976:Basic-Leucine Zipper Transcription Factors; C118265:K8 protein, Human herpesvirus 8; D012097:Repressor Proteins; D014764:Viral Proteins; D056484:Jumonji Domain-Containing Histone Demethylases; C494424:KDM4A protein, human